Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation

Liver Transplantation

Volumn 7, Issue 11, 2001, Pages 976-982

  Seehofer, Daniel ^a   Rayes, Nada ^a   Steinmüller, Thomas ^a   Müller, Andrea R ^a   Settmacher, Utz ^a   Neuhaus, Ruth ^a   Radke, Cornelia ^b   Berg, Thomas ^a   Hopf, Uwe ^a   Neuhaus, Peter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; FAMCICLOVIR; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; LIVER ENZYME; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RECOMBINANT ALPHA2A INTERFERON; STEROID; VIRUS DNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DISEASE COURSE; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOPROPHYLAXIS; LABORATORY TEST; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; REINFECTION; REOPERATION; TREATMENT OUTCOME; VIRUS REPLICATION; VIRUS RESISTANCE;

EID: 0035189205     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2001.28442     Document Type: Article

References (23)

1. Orthotopic liver transplantation for patients with hepatitis B virus related liver disease
2. Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: A pilot study
3. Long-term results of famciclovir for recurrent or de novo hepatitis B virus infection after liver transplantation
4. Beneficial effect of lamivudine in recurrent hepatitis B after liver transplantation
5. Efficacy of lamivudine in controlling hepatitis B virus recurrence after liver transplantation
6. Multicenter study of lamivudine therapy for hepatitis B after liver transplantation
7. Lamivudine as first and second line treatment of hepatitis B infection after liver transplantation
8. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation
9. Drug therapy for chronic hepatitis B: Anti-viral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy
10. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine
11. YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitro full-length viral DNA transfection
12. Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective
13. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
14. Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient
15. Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: High resistance rates in treatment of recurrence but universial prevention if used as low-dose hepatitis B immune globulin
16. Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessitation of therapy
17. Acute exacerbation of chronic hepatitis B after withdrawal of lamivudine therapy
18. Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation
19. Selection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapy
20. Efficacy of lamivudine in controlling hepatitis B virus recurrence after liver transplantation
21. Adefovir dipivoxil for the treatment of lamivudine resistant hepatitis B mutants
22. Combination chemotherapy for hepatitis B virus. The path forward?
23. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin